Vital Signs The Analyst's Perspective - October 2015 Issue

Vital Signs The Analyst's Perspective - October 2015 Issue

RELEASE DATE
04-Dec-2015
REGION
Asia Pacific
Research Code: 9A35-00-41-00-00
SKU: HC02618-AP-MR_16740

$450.00

Special Price $337.50 save 25 %

In stock
SKU
HC02618-AP-MR_16740

$450.00

$337.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This issue of Vital Signs discusses the change in 2015 Mammogram Guidelines, NeoGenomics' acquistion of Clarient from GE, and Tute Genomics' acquisition of Knome.

Table of Contents

Related Research
This research service presents an overview and analysis of the Australian contract research organization (CRO) market. The research service provides market revenue forecasts by phase and therapeutic type and discusses major issues and challenges, unmet needs, and developing trends in the CRO market. The study covers the complete life cycle of the CRO industry, starting from preclinical trials to Phase IV trials and provides detailed information on support services such as central laboratory services, biostatistics, bioanalytics, and data management. The research service analyses market engineering measurements and research and development trends.
More Information
No Index No
Podcast No
Author Christi Bird
Industries Healthcare
WIP Number 9A35-00-41-00-00
Is Prebook No